Clinical Trials Directory

Trials / Completed

CompletedNCT02279082

DFN-02 Open Label Safety Study in Patients With Acute Migraine

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
167 (actual)
Sponsor
Dr. Reddy's Laboratories Limited · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

A multi-center, open-label, safety study of DFN-02 for the Treatment of Acute Migraines

Conditions

Interventions

TypeNameDescription
DRUGDFN-02Active Experimental Drug

Timeline

Start date
2014-09-01
Primary completion
2015-09-01
Completion
2016-03-01
First posted
2014-10-30
Last updated
2018-03-09
Results posted
2017-08-28

Locations

24 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02279082. Inclusion in this directory is not an endorsement.

DFN-02 Open Label Safety Study in Patients With Acute Migraine (NCT02279082) · Clinical Trials Directory